Addressing apoptosis to tumor zip codes.

In the current issue of Cancer, Pasqualini and colleagues report on a study in which they target prostatic tumor vasculature signatures with an apoptosis-inducing, peptidomimetic drug. The authors of this editorial place this vascular-targeting discovery into a broader clinical context while focusing on opportunities and challenges in implementing it further.